Zacks
Top Robotics Stocks Worth Investing Now for Solid Returns
📈
AI Sentiment
Highly Positive
10/10
- Home
- ISRG
as of 02-26-2026 9:36am EST
$508.31
+$2.65
+0.52%
Intuitive develops, produces, and markets a robotic system for assisting minimally invasive surgery. It also provides the instrumentation, disposable accessories, and warranty services for the system. The company has placed more than 10,000 da Vinci systems in hospitals worldwide, with more than 6,000 installations in the US and a growing number in emerging markets.
| Founded: | 1995 | Country: | United States |
| Employees: | N/A | City: | SUNNYVALE |
| Market Cap: | 187.5B | IPO Year: | 1998 |
| Target Price: | $612.40 | AVG Volume (30 days): | 1.9M |
| Analyst Decision: | Buy | Number of Analysts: | 15 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | 7.87 | EPS Growth: | 22.59 |
| 52 Week Low/High: | $425.26 - $603.88 | Next Earning Date: | 04-20-2026 |
| Revenue: | $10,064,700,000 | Revenue Growth: | 20.51% |
| Revenue Growth (this year): | 16.75% | Revenue Growth (next year): | 13.85% |
| P/E Ratio: | 64.25 | Index: | |
| Free Cash Flow: | N/A | FCF Growth: | +91.03% |
Stock Insider Trading Activity of Intuitive Surgical Inc. (ISRG)
Curet Myriam
Sell
EVP & Chief Medical Officer
ISRG Feb 11, 2026
Avg Cost/Share
$494.96
Shares
421
Total Value
$208,378.16
Owned After
409
SEC Form 4
Widman Fredrik
Sell
VP Corporate Controller
ISRG Feb 11, 2026
Avg Cost/Share
$494.96
Shares
133
Total Value
$65,829.68
Owned After
660
SEC Form 4
Curet Myriam
Sell
EVP & Chief Medical Officer
ISRG Feb 10, 2026
Avg Cost/Share
$494.65
Shares
105
Total Value
$51,938.25
Owned After
409
SEC Form 4
Curet Myriam
Sell
EVP & Chief Medical Officer
ISRG Jan 27, 2026
Avg Cost/Share
$532.61
Shares
230
Total Value
$122,500.30
Owned After
409
GUTHART GARY S
Sell
Director
ISRG Jan 27, 2026
Avg Cost/Share
$531.05
Shares
27,300
Total Value
$14,475,672.47
Owned After
15,720
Brosius Mark
Sell
See Remarks
ISRG Dec 15, 2025
Avg Cost/Share
$548.49
Shares
464
Total Value
$254,499.36
Owned After
131
SEC Form 4
Brosius Mark
Sell
SVP & Chief Mfg and Supply Cha
ISRG Dec 15, 2025
Avg Cost/Share
$548.49
Shares
464
Total Value
$254,499.36
Owned After
131
SEC Form 4
Brosius Mark
Sell
SVP & Chief Mfg and Supply Cha
ISRG Dec 12, 2025
Avg Cost/Share
$547.36
Shares
4,500
Total Value
$2,463,120.00
Owned After
131
SEC Form 4
Curet Myriam
Sell
EVP & Chief Medical Officer
ISRG Dec 10, 2025
Avg Cost/Share
$559.90
Shares
104
Total Value
$58,229.60
Owned After
409
SEC Form 4
Curet Myriam
Sell
EVP & Chief Medical Officer
ISRG Dec 1, 2025
Avg Cost/Share
$568.99
Shares
125
Total Value
$71,123.75
Owned After
409
SEC Form 4
| Insider | Ticker | Relationship | Date | Transaction | Avg Cost | Shares | Total Value | Owned After | SEC Forms |
|---|---|---|---|---|---|---|---|---|---|
| Curet Myriam | ISRG | EVP & Chief Medical Officer | Feb 11, 2026 | Sell | $494.96 | 421 | $208,378.16 | 409 | |
| Widman Fredrik | ISRG | VP Corporate Controller | Feb 11, 2026 | Sell | $494.96 | 133 | $65,829.68 | 660 | |
| Curet Myriam | ISRG | EVP & Chief Medical Officer | Feb 10, 2026 | Sell | $494.65 | 105 | $51,938.25 | 409 | |
| Curet Myriam | ISRG | EVP & Chief Medical Officer | Jan 27, 2026 | Sell | $532.61 | 230 | $122,500.30 | 409 | |
| GUTHART GARY S | ISRG | Director | Jan 27, 2026 | Sell | $531.05 | 27,300 | $14,475,672.47 | 15,720 | |
| Brosius Mark | ISRG | See Remarks | Dec 15, 2025 | Sell | $548.49 | 464 | $254,499.36 | 131 | |
| Brosius Mark | ISRG | SVP & Chief Mfg and Supply Cha | Dec 15, 2025 | Sell | $548.49 | 464 | $254,499.36 | 131 | |
| Brosius Mark | ISRG | SVP & Chief Mfg and Supply Cha | Dec 12, 2025 | Sell | $547.36 | 4,500 | $2,463,120.00 | 131 | |
| Curet Myriam | ISRG | EVP & Chief Medical Officer | Dec 10, 2025 | Sell | $559.90 | 104 | $58,229.60 | 409 | |
| Curet Myriam | ISRG | EVP & Chief Medical Officer | Dec 1, 2025 | Sell | $568.99 | 125 | $71,123.75 | 409 |
Latest Intuitive Surgical Inc. News
ISRG Breaking Stock News: Dive into ISRG Ticker-Specific Updates for Smart Investing
Simply Wall St.
Assessing Intuitive Surgical (ISRG) Valuation After Recent 12% Year To Date Share Price Decline
➖
AI Sentiment
Neutral
5/10
MT Newswires
UBS Adjusts Price Target on Intuitive Surgical to $570 From $600, Maintains Neutral Rating
📊
AI Sentiment
Positive
7/10
Zacks
The Zacks Analyst Blog Highlights Oracle, Intuitive Surgical, Analog Devices and Moving iMage Technologies
📊
AI Sentiment
Positive
7/10
Zacks
Zacks Industry Outlook Highlights Intuitive Surgical, Edwards Lifesciences and Electromed
📈
AI Sentiment
Highly Positive
8/10
Zacks
Top Research Reports for Oracle, Intuitive Surgical & Analog Devices
📊
AI Sentiment
Positive
6/10
Insider Monkey
Da Vinci 5 Sparks Optimism Around Intuitive Surgical, Inc. (ISRG)
📈
AI Sentiment
Highly Positive
9/10
Simply Wall St.
How The Intuitive Surgical (ISRG) Story Is Shifting With Dv5, FDA Clears, And Valuation Jitters
📊
AI Sentiment
Positive
7/10
Compare ISRG vs Leading Stocks
See how ISRG stacks up against similar companies in the market
Head-to-Head Comparisons
Share on Social Networks:
Tools & Resources
Enhance your trading experience with our free tools
Disclaimer
The information presented on this page, "ISRG Intuitive Surgical Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.